Wuxi Biologics Holdings is looking to raise up to US$1bn by selling about 2% of Wuxi Biologics (Cayman) Inc (2269 HK). This is the company's 12th placement since it listed in June 2017.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.